GEMoaB GmbH is a privately-owned, clinical-stage biopharmaceutical company based in Dresden, Germany, that is focused on becoming a leading, fully integrated biopharmaceutical company. By focusing on our proprietary next generation UniCAR, RevCAR and TCE platforms, we intend to discover, develop, manufacture and commercialize next generation immunotherapies for the treatment of cancer patients with a high unmet medical need.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Dresden
- Phone
- +49 351 4466 4500
- in****@****oab.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- gemoab.com
- HQ
- Dresden
Gemoab Gmbh Questions
Gemoab Gmbh's helpline number is +49 351 4466 4500
Gemoab Gmbh's website is gemoab.com
Gemoab Gmbh's LinkedIn profile is https://de.linkedin.com/company/gemoab-monoclonals-gmbh
Gemoab Gmbh has
3 employees.
View email and phone details for 3
employees at Gemoab Gmbh.
Gemoab Gmbh's industry is
Biotechnology Research
Gemoab Gmbh's top competitors are
Avencell,
Cellbox Solutions,
Immatics,
Seamless Therapeutics,
Miltenyi Biotec,
Cellex - Cell Expansion Devices Srl,
Swarm Oncology,
Cellex Cell Professionals,
Zytomanufaktur Dresden Gmbh,
Genmar Pharma Gmbh.
Gemoab Gmbh's support email address is info@gemoab.com
Gemoab Gmbh's categories are Biotechnology Research
Gemoab Gmbh's founding year is 2011
